Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing United Jieran Biotechnology appears to have been a China-based healthcare manufacturer focused on products used in hemodialysis rather than a drug-development biotech. Public trade-directory descriptions identify it as a specialist producer of hemodialysis water-treatment systems, concentrated liquid delivery systems, and dialysis powder/liquid used with dialysis machines. The company is described as having been established in 1992 and operating in Beijing, with products marketed as complete dialysis-support solutions for professional service providers. Available evidence suggests it was a commercial-stage medical products company, but there is little reliable public information indicating a therapeutics pipeline, financing history, or broad international corporate footprint. Chinese business-registry style sources further suggest the entity is no longer active and may have been deregistered.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing United Jieran Biotechnology.